Implementing, Advancing and Exploring Telemedicine Programs and Services for Hospitals and Health Systems
6-8 April 2016
His session is titled “Building Telemedicine Contracts for Hospitals & Health Systems” and will focus on:
- Learning key legal, regulatory, and business issues by examining hospital telemedicine arrangements
- Exploring different business models and compensation terms, learning how they can be used in hospital and health system telemedicine contracts
- Obtaining meaningful handouts and tools to incorporate into hospital’s telemedicine services
This two-day, case study-based industry event will focus on implementing, advancing, and expanding telemedicine services to increase patient engagement, advance care coordination, reach underserved populations, achieve efficiency and improve patient outcomes. The event will bring industry leaders together, highlight the best practice achievements, and discuss the current issues and challenges facing telemedicine.
For more information, visit the conference website.
People
Related Insights
June 6, 2025
Energy Current
House Bill 3809 Adds Obligations to Battery Energy Storage Lessees in Texas
On May 29, 2025, House Bill No. 3809 was signed into law by Texas Governor Greg Abbott. Born out of a crop of bills regulating renewable…
June 23, 2025
Events
Third Annual Transaction Solutions Symposium
Foley & Lardner is sponsoring the Third Annual Transaction Solutions Symposium — a premier conference focused on de-risking strategies that enhance deal execution and business outcomes. Rishi Sodhi will be speaking as part of the Tax Liability Insurance: Current Trends, Controversies and Claims panel.
June 5, 2025
Health Care Law Today
GLP-1 Compounded Medications Targeted by Connecticut Attorney General
On May 21, 2025, the Connecticut Office of the Attorney General released a statement and sent letters to Connecticut weight loss clinics, med spas, medical practices and other businesses regarding allegedly or potentially unfair and deceptive conduct relating to compounded GLP-1 medications.